Details for New Drug Application (NDA): 203835
✉ Email this page to a colleague
NDA 203835 describes LOSARTAN POTASSIUM, which is a drug marketed by Aiping Pharm Inc, Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, Zydus Pharms Usa Inc, Apotex, Sandoz, and Teva Pharms, and is included in forty NDAs. It is available from forty-six suppliers. Additional details are available on the LOSARTAN POTASSIUM profile page.
The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
Summary for 203835
| Tradename: | LOSARTAN POTASSIUM |
| Applicant: | Hetero Labs Ltd V |
| Ingredient: | losartan potassium |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 203835
| Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 203835
Suppliers and Packaging for NDA: 203835
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 203835 | ANDA | Camber Pharmaceuticals, Inc. | 31722-700 | 31722-700-05 | 500 TABLET, FILM COATED in 1 BOTTLE (31722-700-05) |
| LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 203835 | ANDA | Camber Pharmaceuticals, Inc. | 31722-700 | 31722-700-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (31722-700-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Aug 12, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Aug 12, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Aug 12, 2015 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
